Non-linear association between ankle-brachial pressure index and prevalence of silent cerebral infarction in Japanese patients with type 2 diabetes

Atherosclerosis

Volumn 222, Issue 2, 2012, Pages 490-494

  Bouchi, Ryotaro ^a   Babazono, Tetsuya ^a   Takagi, Michino ^a   Yoshida, Naoshi ^a   Nyumura, Izumi ^a   Toya, Kiwako ^a   Hanai, Ko ^a   Tanaka, Nobue ^a   Uchigata, Yasuko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Ankle brachial pressure index; Silent cerebral infarction; Type 2 diabetes

Indexed keywords

ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN INFARCTION; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; SILENT CEREBRAL INFARCTION; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; ASIAN CONTINENTAL ANCESTRY GROUP; CEREBRAL INFARCTION; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONLINEAR DYNAMICS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84861344426     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.025     Document Type: Article

References (29)

1. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007, 33:S1-S75.
2. Newman A.B., Siscovick D.S., Manolio T.A., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993, 88:837-845.
3. Leng G.C., Fowkes F.G., Lee A.J., Dunbar J., Housley E., Ruckley C.V. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996, 313:1440-1444.
4. Norman P.E., Davis W.A., Bruce D.G., Davis T.M. Peripheral arterial disease and risk of cardiac death in type 2 diabetes. Diabetes Care 2006, 29:575-580.
5. Tsivgoulis G., Bogiatzi C., Heliopoulos I., et al. Atherosclerosis 2012, 220:407-412.
6. Murabito J.M., Evans J.C., Larson M.G., Nieto K., Levy D., Wilson P.W. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med 2003, 163:1939-1942.
7. O'Hare A.M., Katz R., Shilipak M.G., Cushman M., Newman A.B. Mortality and cardiovascular risk across ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 2006, 113:388-393.
8. Aboyans V., Ho E., Denenberg J.O., Ho L.A., Natarajan L., Criqui M.H. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and non-diabetic subjects. J Vasc Surg 2008, 48:1197-1203.
9. Kobayashi S., Okada K., Koide H., Bokura H., Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997, 28:1932-1939.
10. Longstreth W.T., Dulberg C., Manolio T.A., et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2002, 33:2376-2382.
11. Alberti K.G.M.M., Zimmet P. Definition, diagnosis, and classification of diabetes mellitus and its complications, part 2: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553. for the WHO consultation.
12. Wilkinson C.P., Ferris F.L., Klein R.E., et al. Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682.
13. Yamashina A., Tomiyama H., Takeda K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002, 25:359-364.
14. Shadman R., Criqui M.H., Bundens W.P., et al. Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol 2004, 44:618-623.
15. Bouchi R., Babazono T., Yoshida N., et al. Relationship between chronic kidney disease and silent cerebral infarction in patients with type 2 diabetes. Diabet Med 2010, 27:538-543.
16. Bouchi R., Babazono T., Yoshida N., et al. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes. Hypertens Res 2010, 33:1000-1003.
17. Sasaki M., Hirai T., Taoka T., Higano S., Wakabayashi C., Matsusue E., et al. Discriminating between silent cerebral infarction and deep white matter hyperintensity using combinations of three types of magnetic resonance images: a multicenter observer performance study. Neuroradiology 2008, 50:753-758.
18. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Invest 2010; 1: 212-228.
19. Matsuo S., Imai E., Horio M., et al. Collaborators developing the Japanese equation for estimated GFR revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
20. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
21. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
22. Criqui M.H., McClelland R.L., McDermott M.M., et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010, 56:1506-1512.
23. Vermeer S.E., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol 2007, 6:611-619.
24. Criqui M.H., Denenberg J.O., Langer R.D., Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997, 2:221-226.
25. Criqui M.H., Ninomiya J.K., Wingard D.L., Ji M., Fronek A. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 2008, 52:1736-1742.
26. De Virgilio C., Toosie K., Arnell T., et al. Asymptomatic carotid artery stenosis screening in patients with lower extremity atherosclerosis: a prospective study. Ann Vasc Surg 1997, 11:374-377.
27. O'Rourke M.F., Safar M.E. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005, 46:200-204.
28. Kario K., Pickering T.G., Umeda Y., et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003, 107:1401-1406.
29. Dzau V.J., Antman E.M., Black H.R., et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation 2006, 114:2871-2891.